Case report: pathological complete response in an IIIB non-small cell lung cancer patient after preoperative neoadjuvant nivolumab therapy combined with chemotherapy

RATIONALE: For locally advanced non-small cell lung cancer (NSCLC), the neoadjuvant therapy strategy of preoperative nivolumab combined with chemotherapy has great potential, especially for locally advanced NSCLC which are initially unresectable. They may be cured after neoadjuvant immunotherapy, an...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Luzhen, Chen, Ting, Lai, Huiqin, Zhang, Ao, Zhao, Xianhui, Wu, Jiaming, Hong, Huisi, Wu, Lexia, Lin, Sihong, Wang, Kexin, Zhang, Huatang, Fang, Cantu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
5700
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276206/
https://www.ncbi.nlm.nih.gov/pubmed/35687776
http://dx.doi.org/10.1097/MD.0000000000029336

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9276206/
https://www.ncbi.nlm.nih.gov/pubmed/35687776
http://dx.doi.org/10.1097/MD.0000000000029336

Ejemplares similares